This is B Braun's second introduction of antibiotics into the drug delivery system in 2025, following the launch of Cefazolin 3g, and is part of the company’s strategy to expand its portfolio of ...

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced the launch of its new Cefazolin 3 g, the latest cefazolin dose addition to the DUPLEX Container ...

[2,3] Cefazolin is one of the most commonly used antimicrobials in these patients because of its broad antimicrobial spectrum, favorable pharmacokinetics, and safety. [4,5,6] Heparin is frequently ...